Variant report
Variant | nsv972295 |
---|---|
Chromosome Location | chr9:14920837-14922556 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:22)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:22 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr9:14921019-14921100 | LNCaP | prostate: | n/a | n/a |
2 | FOSL2 | chr9:14920749-14921285 | HepG2 | liver: | n/a | n/a |
3 | FOSL2 | chr9:14920755-14921219 | HepG2 | liver: | n/a | n/a |
4 | FOXA1 | chr9:14920819-14921156 | HepG2 | liver: | n/a | n/a |
5 | FOXA1 | chr9:14920845-14921170 | HepG2 | liver: | n/a | n/a |
6 | FOXA1 | chr9:14920690-14921296 | HepG2 | liver: | n/a | n/a |
7 | FOXA1 | chr9:14920659-14921309 | HepG2 | liver: | n/a | n/a |
8 | FOXA2 | chr9:14920976-14921168 | A549 | lung: | n/a | n/a |
9 | FOXA2 | chr9:14920823-14921137 | HepG2 | liver: | n/a | n/a |
10 | HEY1 | chr9:14920832-14921291 | HepG2 | liver: | n/a | n/a |
11 | HNF4A | chr9:14920865-14921148 | HepG2 | liver: | n/a | n/a |
12 | JUND | chr9:14921398-14921563 | HepG2 | liver: | n/a | n/a |
13 | JUND | chr9:14920867-14921077 | HepG2 | liver: | n/a | n/a |
14 | JUND | chr9:14920827-14921121 | HepG2 | liver: | n/a | n/a |
15 | MAFF | chr9:14920866-14921068 | HepG2 | liver: | n/a | n/a |
16 | MYBL2 | chr9:14920684-14921181 | HepG2 | liver: | n/a | n/a |
17 | POLR2A | chr9:14920988-14921102 | Hela-S3 | cervix: | n/a | n/a |
18 | POLR2A | chr9:14920900-14921214 | Hela-S3 | cervix: | n/a | n/a |
19 | POLR2A | chr9:14920894-14921179 | HepG2 | liver: | n/a | n/a |
20 | RXRA | chr9:14920829-14921102 | HepG2 | liver: | n/a | n/a |
21 | SP1 | chr9:14920798-14921213 | HepG2 | liver: | n/a | n/a |
22 | TCF12 | chr9:14920886-14921126 | HepG2 | liver: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
LDHAP4 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs556435128 | chr9:14920837-14920838 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs185665630 | chr9:14920865-14920866 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs75532023 | chr9:14920884-14920885 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs111881629 | chr9:14920894-14920895 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs572809729 | chr9:14920903-14920904 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs540224129 | chr9:14920904-14920905 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs140026380 | chr9:14920923-14920924 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs55751930 | chr9:14920974-14920975 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs530187410 | chr9:14920976-14920977 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs146299173 | chr9:14920996-14920997 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs139330621 | chr9:14920997-14920998 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs544901127 | chr9:14921024-14921025 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs560002219 | chr9:14921039-14921040 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs527622517 | chr9:14921046-14921047 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs548964518 | chr9:14921066-14921067 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs150003675 | chr9:14921114-14921115 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs531672165 | chr9:14921122-14921123 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs550264935 | chr9:14921127-14921128 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs571720657 | chr9:14921156-14921157 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs148654843 | chr9:14921158-14921159 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs554446642 | chr9:14921178-14921179 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs566373001 | chr9:14921214-14921215 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs533165996 | chr9:14921234-14921235 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs144536221 | chr9:14921236-14921237 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs555361148 | chr9:14921250-14921251 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs201254922 | chr9:14921279-14921280 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs573693080 | chr9:14921296-14921297 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs547130172 | chr9:14921311-14921312 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs543941494 | chr9:14921320-14921321 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs556199954 | chr9:14921329-14921330 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs114622968 | chr9:14921330-14921331 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs73642462 | chr9:14921349-14921350 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs559964070 | chr9:14921389-14921390 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs527537117 | chr9:14921390-14921391 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs369084460 | chr9:14921415-14921416 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs542522769 | chr9:14921481-14921482 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs566830184 | chr9:14921490-14921491 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs560913143 | chr9:14921558-14921559 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs192932090 | chr9:14921568-14921569 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs141133687 | chr9:14921607-14921608 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs571703927 | chr9:14921640-14921641 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs532599136 | chr9:14921656-14921657 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs111994725 | chr9:14921688-14921689 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs2030594 | chr9:14921722-14921723 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs566285139 | chr9:14921728-14921729 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs150926268 | chr9:14921747-14921748 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs555322457 | chr9:14921806-14921807 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs570277698 | chr9:14921821-14921822 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs537829653 | chr9:14921822-14921823 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs538025638 | chr9:14921823-14921824 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Developmental delay | 21147756 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21611746 | CNVD |
Glycine encephalopathy | 21572526 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:14910400-14921000 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
2 | chr9:14919000-14922800 | Enhancers | HepG2 | liver |
3 | chr9:14920600-14924200 | Weak transcription | Adipose Nuclei | Adipose |
4 | chr9:14920600-14935200 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
5 | chr9:14921000-14921200 | Enhancers | Pancreatic Islets | Pancreatic Islet |